Binding of curcumin with glyoxalase I: Molecular docking, molecular dynamics simulations, and kinetics analysis.

Glyoxalase I (GLOI) is a key metalloenzyme in glycolytic pathway by detoxifying reactive alpha-ketoaldehydes such as methylglyoxal. Recent studies demonstrate that the nature product curcumin is an efficient inhibitor of GLOI, but its binding mechanism towards GLOI is still unclear. In the present study, molecular docking and molecular dynamics (MD) simulations were performed to better understand the inhibitory mechanism of curcumin towards GLOI. The enol form of curcumin coordinates with the catalytic zinc ion of GLOI and forms a strong hydrogen bond with Glu 172, whereas its keto tautomer displays unfavorable electrostatic interactions with Glu 172 and Glu 99. The calculated binding free energies suggest that GLOI prefers the primary enol form (DeltaG=-30.38kcal/mol) to the keto tautomer (DeltaG=-24.16kcal/mol). The present work also reveals that bisdemethoxycurcumin binds to GLOI in a similar manner as curcumin and exhibits a slightly less negative predicted binding free energy, which is further validated by our comparative kinetics analysis (Ki=18.2 and 10.3muM for bisdemethoxycurcumin and curcumin, respectively). Results of the study can provide an insight into the development of novel and more effective GLOI inhibitors.

[1]  W. C. Still,et al.  Semianalytical treatment of solvation for molecular mechanics and dynamics , 1990 .

[2]  K. Huse,et al.  Curcumin Inhibits Glyoxalase 1—A Possible Link to Its Anti-Inflammatory and Anti-Tumor Activity , 2008, PloS one.

[3]  K. Tew,et al.  Glutathione S-transferases in normal and malignant human colon tissue. , 1991, Biochimica et biophysica acta.

[4]  Characterization of the gene encoding glyoxalase II from Leishmania donovani: a potential target for anti-parasite drugs. , 2006, The Biochemical journal.

[5]  E. Skrzypczak‐Jankun,et al.  Structure of curcumin in complex with lipoxygenase and its significance in cancer. , 2003, International journal of molecular medicine.

[6]  Paul J Thornalley,et al.  Antitumour activity of S-p-bromobenzylglutathione cyclopentyl diester in vitro and in vivo. Inhibition of glyoxalase I and induction of apoptosis. , 1996, Biochemical pharmacology.

[7]  A D Cameron,et al.  Reaction mechanism of glyoxalase I explored by an X-ray crystallographic analysis of the human enzyme in complex with a transition state analogue. , 1999, Biochemistry.

[8]  P. Kollman,et al.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.

[9]  A. Szent-Györgyi,et al.  Cancerostatic action of methylglyoxal. , 1968, Science.

[10]  A. Warshel,et al.  Computer simulation of the initial proton transfer step in human carbonic anhydrase I. , 1992, Journal of molecular biology.

[11]  M. Spiteller,et al.  DFT and experimental studies of the structure and vibrational spectra of curcumin , 2005 .

[12]  Makoto Muroi,et al.  The identification of an osteoclastogenesis inhibitor through the inhibition of glyoxalase I , 2008, Proceedings of the National Academy of Sciences.

[13]  P. Kollman,et al.  Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models , 1992 .

[14]  R. Holewinski,et al.  Glyoxalase I inhibitors in cancer chemotherapy. , 2003, Biochemical Society transactions.

[15]  M. Uesugi,et al.  Polyproline-rod approach to isolating protein targets of bioactive small molecules: isolation of a new target of indomethacin. , 2007, Journal of the American Chemical Society.

[16]  C. Hodge,et al.  Fitting an inhibitor into the active site of thermolysin: A molecular dynamics case study , 1996, Proteins.

[17]  R. Vince,et al.  Glyoxalase inhibitors. A possible approach to anticancer agents. , 1971, Journal of Medicinal Chemistry.

[18]  S. Tanuma,et al.  Structure-activity relationship of human GLO I inhibitory natural flavonoids and their growth inhibitory effects. , 2008, Bioorganic & medicinal chemistry.

[19]  Martin Billeter,et al.  Essential domain motions in barnase revealed by MD simulations , 2002, Proteins.

[20]  B. Aggarwal,et al.  Curcumin as "Curecumin": from kitchen to clinic. , 2008, Biochemical pharmacology.

[21]  Weihua Li,et al.  Insights into ligand selectivity in estrogen receptor isoforms: molecular dynamics simulations and binding free energy calculations. , 2008, The journal of physical chemistry. B.

[22]  M. Kavarana,et al.  Role of hydrophobic interactions in binding S-(N-aryl/alkyl-N-hydroxycarbamoyl)glutathiones to the active site of the antitumor target enzyme glyoxalase I. , 2000, Journal of medicinal chemistry.

[23]  Charles L. Brooks,et al.  Detailed analysis of grid‐based molecular docking: A case study of CDOCKER—A CHARMm‐based MD docking algorithm , 2003, J. Comput. Chem..

[24]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[25]  Paul J Thornalley,et al.  Inhibition of proliferation of human leukaemia 60 cells by methylglyoxal in vitro. , 1993, Biochemical Society transactions.

[26]  Antonio Morreale,et al.  Structure-Based Discovery of Novel Non-nucleosidic DNA Alkyltransferase Inhibitors: Virtual Screening and in Vitro and in Vivo Activities , 2008, J. Chem. Inf. Model..

[27]  G. Scuseria,et al.  Gaussian 03, Revision E.01. , 2007 .

[28]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[29]  Federico Fogolari,et al.  Protocol for MM/PBSA molecular dynamics simulations of proteins. , 2003, Biophysical journal.

[30]  M. Sanner,et al.  Reduced surface: an efficient way to compute molecular surfaces. , 1996, Biopolymers.

[31]  M. Kavarana,et al.  Pharmacokinetics and antitumor properties in tumor-bearing mice of an enediol analogue inhibitor of glyoxalase I , 2000, Cancer Chemotherapy and Pharmacology.

[32]  M Karplus,et al.  Zinc binding in proteins and solution: A simple but accurate nonbonded representation , 1995, Proteins.

[33]  Ricky Chachra,et al.  Origins of Resistance Conferred by the R292K Neuraminidase Mutation via Molecular Dynamics and Free Energy Calculations. , 2008, Journal of chemical theory and computation.

[34]  Paul J Thornalley.  The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. , 1990, The Biochemical journal.